Amplias interacciones in vivo entre metabolito y proteína reveladas por análisis sistemáticos a gran escala

Xiyan Li1, Tara A Gianoulis, Kevin Y Yip

  • 1Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305-5120, USA.

Cell
|November 2, 2010
PubMed
Resumen

Este estudio revela que las pequeñas moléculas, incluido el ergosterol, se unen con frecuencia a las proteínas de la levadura, descubriendo numerosas nuevas interacciones. Estos hallazgos sugieren que los pequeños metabolitos juegan un papel regulador más amplio en las funciones celulares de lo que se entendía anteriormente.

Videos de Conceptos Relacionados

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.7K
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.5K
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
431